Drugs & Targets Caris to perform genomic profiling for Hoosier Cancer Research Network Bladder Cancer Study May 03, 2019Vol.45 No.18
Drugs & TargetsFree FDA approves Balversa for urothelial carcinoma with FGFR genetic alterations April 19, 2019Vol.45 No.16
Drugs & TargetsFree FDA expands pembrolizumab indication for first-line treatment of NSCLC April 19, 2019Vol.45 No.16
Drugs & TargetsFree Aprea Therapeutics receives FDA Fast Track and Orphan Drug designations for APR-246 for MDS April 19, 2019Vol.45 No.16
Drugs & TargetsFree Intensity Therapeutics receives Fast Track designation for development of INT230-6 in breast cancer April 19, 2019Vol.45 No.16
Drugs & TargetsFree Stanford partners with Notable and Tempus to make rapid personalized treatment in blood cancer patients April 19, 2019Vol.45 No.16
Drugs & TargetsFree OncoSec anounces collaboration with Duke to study TAVO + plasmid DNA vaccines in breast cancer April 19, 2019Vol.45 No.16
